1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGFR 21L858R MutationNon-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorRecruitingNot applicable2023-10-26NCT06102928